Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
View MissionIR's Instablogs on:
  • Chembio Diagnostics, Inc. (CEMI) Announces Membership In Russell Global Index

    Point-of-care diagnostics test leader Chembio Diagnostics announced it will soon join the Russell Global Index. According to a preliminary list of additions posted on June 21 at www.russell.com/indexes, the listing will happen on June 28, when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes.

    Russell Global Index membership remains in place for one year and means automatic inclusion in the appropriate large-cap, small-cap and all-cap indexes, as well as the applicable style, sector, and country indexes. Membership for Russell's equity indexes is determined chiefly by objective market-capitalization rankings and style attributes. Chembio's stock will be included in Russell's Micro-Cap Index.

    Chembio continues to build momentum with both sales and product development and is currently in a very strong position. The company's membership in the Russell Global Index is occurring at a time when Chembio has experienced four consecutive years of profitability and revenue growth. The company now has three FDA-approved rapid HIV tests, including its oral fluid HIV test which is pending CLIA waiver and strong international sales. Chembio is additionally developing a robust POC product pipeline based on the company's patented DPP technology.

    "We are very pleased to join the list of successful companies comprising the Russell Global Index and look forward to the enhanced visibility of our membership," said Chembio Chairman and CEO Lawrence A. Siebert.

    Chembio Diagnostics is engaged in developing, manufacturing, licensing, and marketing proprietary rapid diagnostic tests in the burgeoning $10 billion point-of-care testing market. The company is headquartered in Medford, N.Y., and has approximately 170 employees. Chembio is licensed by the FDA and the USDA and is also certified for the global market under the International Standards Organization (ISO) directive 13.485.

    For more information, visit www.chembio.com

    Please see disclaimer on the MissionIR website
    http://www.missionir.com/disclaimer.html

    Tags: CEMI
    Jun 28 3:06 PM | Link | Comment!
  • VistaGen Therapeutics, Inc. (VSTA) Issues Update On $36M Strategic Financing Agreement With Autlion

    VistaGen Therapeutics, a biotech company applying pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, today provided an update on the status of its strategic financing agreement with Autilion AG.

    VistaGen in April signed an initial agreement with Autilion, a Bergamo Acquisition Corp. subsidiary, in which Autilion committed to invest $36 million in VistaGen in consideration for 72 million shares of restricted VistaGen common stock, at a price of $0.50 per share, in a series of closings ending on or before September 30, 2013.

    Under the terms of the parties' amended agreement, the parties today report that they have completed a first closing and scheduled additional closings to occur in July, August, and September 2013. As previously announced, the self-placed strategic financing does not include warrants or investment banking fees.

    "I met with Autilion's team earlier this week, and we have been working closely with them since signing our agreement in April," Shawn K. Singh, VistaGen's CEO, stated in the press release. "We are confident and excited about completing this transformative financing. Building on the positive developments in our labs presented during the Annual Meetings of the Society of Toxicology and International Society of Stem Cell Research in March and this month, respectively, we look forward to accelerating our lead programs towards valuable outcomes for our shareholders."

    VistaGen's drug rescue activities integrate the company's human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with modern medicinal chemistry to create novel, safer chemical variants (Drug Rescue Variants) of once-promising small molecule drug candidates.

    For more information, visit www.vistagen.com

    Please see disclaimer on the MissionIR website
    http://www.missionir.com/disclaimer.html

    Tags: VSTA
    Jun 28 3:04 PM | Link | Comment!
  • Billabong US Partners With Planet Payment, Inc. (PLPM) Pay In Your Currency Solution

    Leading international multi-currency payment processor Planet Payment announced today that Vantiv, a leading provider of payment processing services and other similar technology solutions for both merchants and financial institutions alike, launched Planet Payment's Pay in Your Currency. The service is currently being implemented at 85 Billabong storefronts across the US. Australia-based Billabong is a leading multi-brand, distribution, and international manufacturing organization focused specifically on surf wear and sports apparel for consumers throughout the world. Billabong currently manufactures and distributes goods to over 100 countries, representing some of the biggest names in the athletic industry.

    "As a global brand with a large international following, Billabong's customers come and shop in our U.S. stores from across the globe," commented retail IT manager at Billabong USA, Roger Moreno. "We strive to provide our valued international customers with a better, more comfortable shopping experience and we believe that the Pay in Your Currency solution - provided through Vantiv - helps us achieve this goal by allowing them to pay in their home currency."

    The Pay in Your Currency service allows international travelers and shoppers to pay for purchases using a Visa® or MasterCard® alongside the great option to pay in their own home currency at the point of sale, rather than relying on their financial or banking institution to perform the conversion, often times for a prominent fee. The service insures better clarity, ultimately identifying international purchases and then allowing for the option to pay in a choice countries currency. Planet Payment currently provides services in more than 20 countries and territories across the Asia Pacific region, North America, the Middle East, Africa, and Europe.

    "Vantiv is pleased to launch the Pay in Your Currency solution at Billabong," said Donald Boeding who currently sits as president of merchant services at Vantiv. "It is our top priority to provide our merchant clients with innovative, value-added payment solutions that allow them to do more than simply process payments. Our relationship with Planet Payment is a prime example of how our partner relationships enable merchants like Billabong to increase sales and provide new payments functionality."

    "The Pay in Your Currency solution eliminates the guess work associated with international transactions," commented chief executive officer of Planet Payment, Philip D. Beck, "Savvy businesses, like Billabong, are looking for new ways to increase sales from their international clientele, improve customer service and increase profitability. Offering Pay in Your Currency allows businesses to accomplish these objectives."

    For more information, please visit www.vantiv.com

    Please see disclaimer on the MissionIR website
    http://www.missionir.com/disclaimer.html

    Tags: PLPM
    Jun 27 5:45 PM | Link | Comment!
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.